From an article by Tim Boreham in the Australian today.....was written a while ago obviously
Paradigm Biopharmaceuticals (PAR) $2.05
Palla’s lowly $86m market cap contrasts with what Palla’s Ritchie dubs the “hot and heavy” valuations ascribed to the medicinal cannabis sector, which is also focused on pain relief.
Another interesting comparison is the $394m market worth of Paradigm, which is seeking to repurpose an old deep-vein thrombosis drug for osteoarthritis pain.
So far the compound, renamed Zilosul, has worked wonders with the creaking knees and joints of ex-footballers including former Carlton great Greg Williams, while fellow Brownlow medallist Chris Judd and “Leaping” Leo Barry have invested in the company.
The drug is not approved and only available under a special access theme and is subject to two separate trials.
“Real world evidence” of 205 patients with knee osteoarthritis suggests pain reduction of more than 50 per cent. If approved — and it’s a big if — Zilosul would be worth billions.
- Forums
- ASX - By Stock
- research reports and media
From an article by Tim Boreham in the Australian today.....was...
-
-
- There are more pages in this discussion • 4,284 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $84.05M |
Open | High | Low | Value | Volume |
25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 9700 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 108741 | 0.240 |
4 | 64258 | 0.235 |
8 | 113649 | 0.230 |
5 | 71572 | 0.225 |
5 | 55537 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 1600 | 1 |
0.260 | 62000 | 2 |
0.265 | 66950 | 4 |
0.270 | 35288 | 4 |
0.275 | 23636 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online